Establishing Mobile Transcranial Magnetic Stimulation
ID: NCT06748209
Our intelligence engine has synthesized this trial record to answer your most important questions in clear, simple terms:
In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all affiliated with MUSC and within 2-hours driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable feasibility, safety, and efficacy lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option, both in our state and across the US.
Read Full Scientific Objectives & Methods
In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all within 90 minutes driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option. This would open up access to TMS for millions of patients with treatment resistant depression who cannot be treated in the current model. After this pilot feasibility and efficacy study, future research would use mobile TMS units for siting at residential care facilities, or remote hospitals and clinics. Investigators aim to determine whether it is possible to assemble and build a functioning mobile TMS unit. After assembling the van, investigators will then recruit up to 30 treatment-resistant depression patients who live near one of three satellite MUSC clinics. These clinics are all within a 2 hour drive from the MUSC Charleston campus. Investigators will treat these patients, open label, with FDA approved accelerated TMS (6 sessions each day, over 2 hours, for 5 days, spread over one or two weeks). Investigators will measure TMS effectiveness using standard depression rating scales. Importantly, investigators will also collect the costs of performing the TMS which will inform whether MUSC or other health delivery systems might adopt this TMS method.
FDA cleared TMS
This is FDA approved TMS
Treatment Arms Description
This will be FDA approved Left Prefrontal TMS for treating depression, we will be performing this within a VA, located at clinics throughout SC.
- Adult (22-80 years old)
- Have treatment-resistant depression as defined by the e-Mini, and the antidepressant treatment history form (ATHF short).
- Be able to read and communicate in English.
- Able to provide their own consent.
- Access to a computer with videoconferencing ability for initial consent and telescreen.
- Patients with unstable medical conditions that might make TMS unsafe. This includes current poorly controlled seizures.
- Ferromagnetic metal in the head.
- Pregnant.
- Currently active substance abuse except tobacco.
Primary Outcome Measures
- Percent of depression responders — Time Frame: From baseline to 1 week immediately after treatment week
Number of patients with \>50% improvement in Phq-9 scores before and then after 5 days of treatment
- Improvement in Depression Symptoms — Time Frame: From baseline to 1 week immediately after treatment week
Change in Phq-9 ratings from baseline to end of treatment
This trial is recruiting at 1 study facilities worldwide. Click below to see if there is a clinic or hospital in your area:
Show All 1 Facilities & Contact Sites
Want to apply or inquire about joining this study? Fill out this simple questionnaire, and our assistant will instantly generate a professional email draft you can copy and send to the central contact coordinator listed above!
View Official Medical/Scientific Title
Portable Transcranial Magnetic Stimulation (TMS) in a Van for Treatment-Resistant Depression